Public Consultation on the Post Market Review of Products Used in the Management of Diabetes on Stage One: Blood Glucose Test Strips

Page last updated: 19 December 2012

Stakeholder Forum Outcomes

The Stakeholder Forum was held in Canberra on 19 November 2012 for Stage One regarding Blood Glucose Test Strips.

The Forum provided a further opportunity for stakeholders to contribute to Stage One of the Review. The Forum summary is now available for viewing:

Stakeholder Forum Summary for Stage One of the Diabetes Review on Blood Glucose Test Strips - Word version (44 KB)

Stakeholder Forum Summary for Stage One of the Diabetes Review on Blood Glucose Test Strips - PDF version (251 KB)

Public Submissions

The Call for Submissions closed on 15 November 2012. The Department appreciates the contribution of all organisations and individuals who made a submission.

Unless otherwise requested, submissions addressing Terms of Reference 5 to 7 have been published below. This Stage of the Review focussed on the utilisation and patterns of use of self-monitoring of blood glucose (SMBG) and the clinical outcomes and benefits of SMBG for people with type 2 diabetes not treated with insulin.

Some of the contents of these submissions may have been included in the draft Report. Submissions, or parts thereof, that are intended to remain confidential should have been clearly marked as such and justifications provided. The Department of Health and Ageing has not published submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.

Responsibility for copyright in submissions resides with the author(s), not with the Department of Health and Ageing.

All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.

More information is available at Post Market Review of Products Used in the Management of Diabetes. If you have difficulty accessing the information provided and need further assistance, please send an email to


  • The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
  • The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
  • The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquires and assessments about those matters or seek independent advice.
  • Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.
  • The Commonwealth reserves the right not to publish a submission or part of a submission that it considers defamatory or otherwise inappropriate for publication.

Table of Submissions

Submission Author Name Document link Date Received
1 Michael Porter Sugarman Submission 1 (PDF 125KB) 31/10/2012
2 Australian Medical Association Submission 2 (PDF 79KB) 13/11/2012
3 Consumer Not for publication 13/11/2012
4 Roche Diagnostics Australia Pty Limited Submission 4 (PDF 971KB) 13/11/2012
5 AIHW Submission 5 (PDF 299KB) 14/11/2012
6 Royal Australian College of General Practitioners Submission 6 (PDF 234KB) 14/11/2012
7 Professor Stephen Colagiuri Submission 7 (PDF 376KB) 14/11/2012
8 Consumers Health Forum of Australia Submission 8 (PDF 301KB) 14/11/2012
9 NPS -Medicine Wise Submission 9 (PDF 416KB) 14/11/2012
10 Bermaci Consulting Submission 10 (PDF 464KB) 14/11/2012
11 Medical Technology Association of Australia Submission 11 (PDF 193KB) 15/11/2012
12 Medical Specialities Australia Submission 12 (PDF 17KB) 14/11/2012
13 Sanofi Submission 13 (PDF 30KB) 15/11/2012
14 IVD Australia Submission 14 (PDF 757KB) 15/11/2012
15 Diabetes Association of the NT, Healthy Living Submission 15 (PDF 219KB) 15/11/2012
16 Boehringer Ingelheim Submission 16 (PDF 281KB) 15/11/2012
17 Pharmaceutical Society of Australia Submission 17 (PDF 98KB) 15/11/2012
18 Professional Peak Body Not for publication 15/11/2012
19 Australian College Nursing Submission 19 (PDF 298KB) 15/11/2012
20 Royal College of Pathologists Australasia Submission 20 (PDF 34KB) 15/11/2012
21 Medicines Australia Submission 21 (PDF 191KB) 15/11/2012
22 Dietitians Association of Australia Submission 22 (PDF 200KB) 15/11/2012
23 Martin's Chemist Submission 23 (PDF 165KB) 15/11/2012
24 Diabetes Australia Submission 24 (PDF 844KB) 15/11/2012
25 Australian Centre for Behavioural Research in Diabetes Submission 25 (PDF 840KB) 15/11/2012
26 AstraZeneca and Bristol-Meyers Squibb Submission 26 (PDF 40KB) 15/11/2012
27 Abbott Australasia Trading as Abbott Diabetes Care Not for publication 15/11/2012
28 Industry Organisation Not for publication 15/11/2012
29 Australian Diabetes Council Submission 29 (PDF 313KB) 15/11/2012
30 Australian Diabetes Educators Association Submission 30 (PDF 308KB) 15/11/2012
31 Pharmacy Guild of Australia Submission 31 (PDF 928KB) 15/11/2012
32 Royal Australasian College of Physicians Submission 32 (PDF 89KB) 22/11/2012
33 Diabetes WA Submission 33 (PDF 685KB) 22/11/2012